Monographie - Cefiderocol sulfate tosylate

Son güncelleme :
05/12/2025

Cefiderocol sulfate tosylate

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fetcroja

Almanya, Büyük Britanya, Fransa, İrlanda, İspanya, İsveç, İtalya, Macaristan, Meksika

Kaynaklar : Cefiderocol sulfate tosylate

	tip	yayın
2093	Laboratuar	Cefiderocol (Fetcroja®)- Summary of Product Characteristics Shionogi B.V. 2020
4528	Dergi	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4634	Dergi	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458
4801	Dergi	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:
4943	Dergi	D'Huart E, Boutouha I, Berardi C, Vigneron J, Demore B, Charmillon A. Stability of Nine Time-Dependent Antibiotics for Outpatient Parenteral Antimicrobial Therapy (OPAT) Use Antibiotics 2025 Antibiotics 2025, 14(5),
4964	Laboratuar	GLUCONATE DE CALCIUM 10 % B.BRAUN, solution pour perfusion - Résumé des caractéristiques du produit. B BRAUN MELSUNGEN AG 2019

Mentions Légales